Please login to the form below

Not currently logged in
Email:
Password:

imetelstat

This page shows the latest imetelstat news and features for those working in and with pharma, biotech and healthcare.

Geron poleaxed as partner J&J abandons only pipeline drug

Geron poleaxed as partner J&J abandons only pipeline drug

raising questions about imetelstat’s potential in particular and the emerging telomerase inhibitor class in general. ... Geron expects the transition of the complete imetelstat program to occur over approximately 12 months with operational support from

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...